Interparfums, Inc. (IPAR)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NASDAQ
Market Cap: $4.27B
Last updated: Nov 17, 2026 at 11:06 AM ET
Interparfums, Inc. (IPAR) Stock Forecast
Analysts expect Interparfums (IPAR) to earn $4.89 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.50B. Of 6 analysts, 2 rate the stock Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 2.83, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 33% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 2 | 33.3% |
| Hold | 3 | 50.0% |
| Sell | 1 | 16.7% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 6
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 4.1% and revenue estimates rise 6.7%.
- Fiscal year ending Dec 31, 2026
- $4.89
- EPS consensus, revenue $1.50B
- Fiscal year ending Dec 31, 2027
- $5.09
- EPS consensus, revenue $1.60B
- Next report
- Jan 19, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.89 | $4.85 to $4.99 | 5 | $1.50B | $1.49B to $1.51B | 5 |
| Dec 31, 2027 | $5.09 | $4.95 to $5.48 | 5 | $1.60B | $1.57B to $1.65B | 6 |
Quarterly Estimates
The EPS consensus rises from $0.44 for the quarter ending Dec 31, 2026 to $1.33 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.44 | $0.40 to $0.48 | 6 | $387.95M | $366.32M to $412.59M | 6 |
| Mar 31, 2027 | $1.33 | $1.33 to $1.33 | 1 | $357.71M | $353.53M to $361.90M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.6% from $4.86.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.89 | $4.89 | $4.89 | $4.89 | $4.86 | +0.6% |
| Fiscal year ending Dec 31, 2027 | $5.09 | $5.20 | $5.20 | $5.20 | $5.24 | -2.9% |
| Quarter ending Mar 31, 2027 | $1.33 | $1.38 | $1.38 | $1.38 | $1.38 | -3.6% |
Frequently Asked Questions About IPAR
What is the IPAR stock forecast?
Consensus analyst estimates put Interparfums's EPS at $4.89 for the fiscal year ending Dec 31, 2026, on revenue of $1.50B. The consensus rating from 6 analysts is Hold.
How do analysts rate IPAR stock?
Of 6 analysts covering Interparfums, 0 rate it Strong Buy, 2 Buy, 3 Hold, 1 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from IPAR next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.89, with estimates from $4.85 to $4.99 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $5.09, with estimates from $4.95 to $5.48 from 5 analysts.
What revenue do analysts expect from Interparfums next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.50B, with estimates from $1.49B to $1.51B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.60B, with estimates from $1.57B to $1.65B.
How many analysts cover IPAR?
6 analysts rate Interparfums stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
IPAR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors